The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
Open accessAbstract
Metastasis of cancer cells is a complex process involving multiple steps including invasion, angiogenesis, and trafficking of cancer cells through blood vessels, extravasations, organ-specific homing, and growth. While matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines play a major role in invasion and angiogenesis, chemokines such as stromal derived factor-1alpha (SDF-1alpha) and their receptors such as CXCR4 are thought to play a critical role in motility, homing, and proliferation of cancer cells at specific metastatic sites. We and others have previously reported that the extracellular signal-activated transcription factor NF-kappaB up-regulates the expression of matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines in highly metastatic breast cancer cell lines. In this report, we demonstrate that NF-kappaB regulates the motility of breast cancer cells by directly up-regulating the expression of CXCR4. Overexpression of the inhibitor of kappaB (IkappaB) in breast cancer cells with constitutive NF-kappaB activity resulted in reduced expression of CXCR4 and a corresponding loss of SDF-1alpha-mediated migration in vitro. Introduction of CXCR4 cDNA into IkappaB-expressing cells restored SDF-1alpha-mediated migration. Electrophoretic mobility shift assays and transient transfection assays revealed that the NF-kappaB subunits p65 and p50 bind directly to sequences within the -66 to +7 region of the CXCR4 promoter and activate transcription. We also show that the cell surface expression of CXCR4 and the SDF-1alpha-mediated migration are enhanced in breast cancer cells isolated from mammary fat pad xenografts compared with parental cells grown in culture. A further increase in CXCR4 cell surface expression and SDF-1alpha-mediated migration was observed with cancer cells that metastasized to the lungs. Taken together, these results implicate NF-kappaB in the migration and the organ-specific homing of metastatic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMD231 cells were obtained from Dr. Harikrishna Nakshatri in 2009 and are a derivative of the MDA-MB-231 cell line (19).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,582
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Self-citationBargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 614
Research works printed but not linked: 8
- Sato, 1993, Oncogene, 8, 395
- Andela, 2000, Cancer Res., 60, 6557
- Dong, 1999, Cancer Res., 59, 3495
- Shattuck-Brandt, 1997, Cancer Res., 57, 3032
- Bachelder, 2002, Cancer Res., 62, 7203
- Koshiba, 2000, Clin. Cancer Res., 6, 3530
- Murakami, 2002, Cancer Res., 62, 7328
- Scotton, 2002, Cancer Res., 62, 5930
Cited by
Sorted by citations
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.49 · Cited by 2,251
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,586
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S. R., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,132
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21358 · Cited by 1,049
Sheridan, C. A., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat‐Nakshatri, P., Turner, C. H., Goulet, R. J., Badve, S., & Nakshatri, H. (2006) · Breast Cancer Research · doi:10.1186/bcr1610 · Cited by 1,013
Self-citationAggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 812
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 808
Kucia, M., Reca, R., Miękus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0342 · Cited by 761
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. R. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 759
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E. N., Piwnica-Worms, D. R., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura‐Morgan, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 671
Busillo, J. M., & Benovic, J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 651
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A.-W., Sun, Y., Schmidt, K. F., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
Transcriptional profiling of the LPS induced NF-κB response in macrophages
Sharif, O., Bolshakov, V. N., Raines, S., Newham, P., & Perkins, N. D. (2007) · BMC Immunology · doi:10.1186/1471-2172-8-1 · Cited by 513
Tomchuck, S. L., Zwezdaryk, K. J., Coffelt, S. B., Waterman, R. S., Danka, E. S., & Scandurro, A. B. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0563 · Cited by 449
Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK
Hagemann, T., Wilson, J. L., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K. A., Klemm, F., Pukrop, T., Binder, C. R., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 433
The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba‐Surma, E. K., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 433
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 423
The chemokine system and cancer
Balkwill, F. R. (2011) · The Journal of Pathology · doi:10.1002/path.3029 · Cited by 425
Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.29.3.1 · Cited by 407
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Lee, S. T., Li, Z., Wu, Z., Aau, M., Guan, P., Karuturi, R. K. M., Liou, Y. C., & Yu, Q. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.011 · Cited by 412
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Kryczek, I., Wei, S., Keller, E. T., Liu, R., & Zou, W. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2006 · Cited by 337
Inflammation: A driving force speeds cancer metastasis
Wu, Y., & Zhou, B. P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9699 · Cited by 327
Masjedi, A., Hashemi, V., Hojjat-Farsangi, M., Ghalamfarsa, G., Azizi, G., Yousefi, M., & Jadidi-Niaragh, F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.177 · Cited by 303
Breast cancer lung metastasis: Molecular biology and therapeutic implications
Jin, L., Han, B., Siegel, E. L., Cui, Y., Giuliano, A. E., & Cui, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1456599 · Cited by 308
Dambly‐Chaudière, C., Cubedo, N., & Ghysen, A. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-23 · Cited by 297
O’Hayre, M., Salanga, C. L., Handel, T. M., & Allen, S. J. (2008) · Biochemical Journal · doi:10.1042/bj20071493 · Cited by 303
Furusato, B., Mohamed, A. A. M., Uhlén, M., & Rhim, J. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02548.x · Cited by 305
Functions of CXCL12 and CXCR4 in breast cancer
Luker, K. E., & Luker, G. D. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.021 · Cited by 293
Transcription factors control invasion: AP-1 the first among equals
Ozanne, B. W., Spence, H. J., McGarry, L., & Hennigan, R. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209759 · Cited by 294
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wang, W., Nag, S. A., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 287
Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · PubMed · Cited by 281
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Zhou, W., Guo, S., Liu, M., Burow, M. E., & Wang, G. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170830111531 · Cited by 286
Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3946 · Cited by 279
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Shen, H., & Tergaonkar, V. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0315-0 · Cited by 281
Keklikoglou, I., Körner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T. N., Schneeweiß, A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 279
Kato, M., Kitayama, J., Kazama, S., & Nagawa, H. (2003) · Breast Cancer Research · doi:10.1186/bcr627 · Cited by 267
Organ selectivity in metastasis: regulation by chemokines and their receptors
Ben‐Baruch, A. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9097-3 · Cited by 264
The NF-κB Pathway and Cancer Stem Cells
Rinkenbaugh, A. L., & Baldwin, A. S. (2016) · Cells · doi:10.3390/cells5020016 · Cited by 265
Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer
Schimanski, C. C., Schwald, S., Simiantonaki, N., Jayasinghe, C., Gönner, U., Wilsberg, V., Junginger, T., Berger, M. R., Galle, P. R., & Moehler, M. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1195 · Cited by 262
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Dubrovska, A., Cojoc, M., Peitzsch, C., Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 274
Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis
Hagan, S., Al‐Mulla, F., Mallon, E., Oien, K. A., Ferrier, R., Gusterson, B. A., García, J. J. C., & Kölch, W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0283 · Cited by 253
Clines, G. A., & Guise, T. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00543 · Cited by 255
Righi, E., Kashiwagi, S., Yuan, J., Santosuosso, M., Leblanc, P. R., Ingraham, R., Forbes, B., Edelblute, B., Collette, B., Xing, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3143 · Cited by 252
CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer
Cabıoğlu, N., Yazıcı, S., Arun, B., Broglio, K. R., Hortobágyi, G. N., Price, J. E., & Şahin, A. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0014 · Cited by 246
Chinni, S. R., Sivalogan, S., Dong, Z., Filho, J. C. T., Deng, X., Bonfil, R. D., & Cher, M. L. (2005) · The Prostate · doi:10.1002/pros.20318 · Cited by 253
Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.327.2.6 · Cited by 238
The Role of chemokine receptor CXCR4 in breast cancer metastasis.
Mukherjee, D., & Zhao, J. (2013) · Europe PMC (PubMed Central) · Cited by 235
Elbaz, M., Nasser, M. W., Ravi, J., Wani, N. A., Ahirwar, D. K., Zhao, H., Oghumu, S., Satoskar, A. R., Shilo, K., Carson, W. E., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.010 · Cited by 233
Ren, D., Yang, Q., Dai, Y., Guo, W., Du, H., Song, L., & Peng, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0688-6 · Cited by 238
Nuclear factor-κB: a friend or a foe in cancer?
Shishodia, S., & Aggarwal, B. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.026 · Cited by 230
NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases
Sarkar, F. H., Li, Y., Wang, Z. P., & Kong, D. (2008) · International Reviews of Immunology · doi:10.1080/08830180802276179 · Cited by 234
Hadadi, É., Taylor, W. R., Li, X., Aslan, Y., Vilotte, M., Rivière, J., Duvallet, G., Auriau, C., Dulong, S., Raymond‐Letron, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16890-6 · Cited by 230
Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
Teo, H., Ghosh, S., Luesch, H., Ghosh, A., Wong, E. T., Malik, N. B. A., Orth, A. P., Jesus, P. D. D., Perry, A. S., Oliver, J. D., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2080 · Cited by 229
Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
Rani, A., Stebbing, J., Giamas, G., & Murphy, J. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00245 · Cited by 224
Dewan, M. Z., Ahmed, S. M., Iwasaki, Y., Ohba, K., Toi, M., & Yamamoto, N. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.06.004 · Cited by 213
Kukreja, P., Abdel‐Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209
The chemokine network in cancer - much more than directing cell movement
Kulbe, H., Levinson, N. R., Balkwill, F. R., & Wilson, J. L. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041814hk · Cited by 214
CXCR4 in breast cancer: oncogenic role and therapeutic targeting
Yao, Q., Xu, C., Zhao, H., & Chen, H. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s84932 · Cited by 217
Mann, A. P., Verma, A. K., Sethi, G., Manavathi, B., Wang, H., Fok, J. Y., Kunnumakkara, A. B., Kumar, R., Aggarwal, B. B., & Mehta, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1457 · Cited by 205
The NF-κB/IκB signaling system: A molecular target in breast cancer therapy
Wu, J. T., & Kral, J. G. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.06.006 · Cited by 204
The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis
Wong, C.-W., Dye, D. E., & Coombe, D. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/340296 · Cited by 210
CXCR4 expression mediates glioma cell invasiveness
Ehtesham, M., Winston, J., Kabos, P., & Thompson, R. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209302 · Cited by 198
Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 199
Puar, Y., Shanmugam, M. K., Fan, L., Arfuso, F., Sethi, G., & Tergaonkar, V. (2018) · Biomedicines · doi:10.3390/biomedicines6030082 · Cited by 200
Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402305200 · Cited by 194
CXCR4 Expression Increases Liver and Lung Metastasis in a Mouse Model of Pancreatic Cancer
Saur, D., Seidler, B., Schneider, G., Algül, H., Beck, R., Senekowitsch–Schmidtke, R., Schwaiger, M., & Schmid, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.056 · Cited by 194
Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820459116 · Cited by 184
Nagendraprabhu, P., & Sudhandiran, G. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9342-5 · Cited by 183
Chemokines: novel targets for breast cancer metastasis
Ali, S., & Lazennec, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9073-z · Cited by 182
Kang, H., Watkins, G., Parr, C., Douglas-Jones, A. G., Mansel, R. E., & Jiang, W. G. (2005) · Breast Cancer Research · doi:10.1186/bcr1022 · Cited by 178
Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Pratheeshkumar, P., Sreekala, C., Zhang, Z., Budhraja, A., Ding, S., Son, Y., Wang, X., Hitron, J. A., Hyun-Jung, K., Wang, L., et al. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833035 · Cited by 180
Veldkamp, C. T., Peterson, F. C., Pelzek, A. J., & Volkman, B. F. (2005) · Protein Science · doi:10.1110/ps.041219505 · Cited by 175
Shanmugam, M. K., Ahn, K. S., Hsu, A., Woo, C. C., Yuan, Y., Tan, K. H. B., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Koh, A. P.-F., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01294 · Cited by 176
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Sleightholm, R. L., Neilsen, B. K., Li, J., Steele, M. M., Singh, R. K., Hollingsworth, M. A., & Oupický, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.012 · Cited by 171
Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target
Jonckheere, S., Adams, J., Groote, D. D., Campbell, K., Berx, G., & Goossens, S. (2021) · Cells Tissues Organs · doi:10.1159/000512218 · Cited by 179
Zeng, Y., Guo, Z., Wu, M., Chen, F., & Chen, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01960-1 · Cited by 197
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
Schimanski, C. C., Bahre, R., Gockel, I., Müller, W. E. G., Frerichs, K., Horner, V. L., Teufel, A., Simiantonaki, N., Biesterfeld, S., Wehler, T., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603251 · Cited by 171
CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
Mousavi, A. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.11.007 · Cited by 171
Fidoamore, A., Cristiano, L., Antonosante, A., d’Angelo, M., Giacomo, E. D., Astarita, C., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2016) · Stem Cells International · doi:10.1155/2016/6809105 · Cited by 175
Involvement of Chemokine Receptors in Organ-Specific Metastasis
Zlotnik, A. (2006) · KARGER eBooks · doi:10.1159/000092973 · Cited by 162
Sweeney, C. J., Mehrotra, S., Sadaria, M. R., Kumar, S., Shortle, N. H., Roman, Y., Sheridan, C., Campbell, R. A., Murry, D. J., Badve, S., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0030 · Cited by 156
Self-citationTrail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells
Ishimura, N., Isomoto, H., Bronk, S. F., & Gores, G. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00242.2005 · Cited by 155
Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., & Wilson, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0957 · Cited by 158
Cabıoğlu, N., Gong, Y. Y., Islam, R., Broglio, K. R., Sneige, N., Şahin, A. A., Gonzalez-Angulo, A. M., Morandi, P., BUCANA, C. D., Hortobágyi, G. N., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm060 · Cited by 151
Rennebeck, G., Martelli, M. G., & Kyprianou, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2763 · Cited by 146
Hochreiter, A. E., Xiao, H., Goldblatt, E. M., Gryaznov, S. M., Miller, K. D., Badve, S., Sledge, G. W., & Herbert, B.-S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2760 · Cited by 146
Self-citationJorcyk, C. L., Tawara, K., & Jorcyk, C. L. (2011) · Cancer Management and Research · doi:10.2147/cmr.s18101 · Cited by 153
CXCR4-directed theranostics in oncology and inflammation
Kircher, M., Herhaus, P., Schottelius, M., Buck, A. K., Werner, R. A., Wester, H., Keller, U. B., & Lapa, C. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1290-8 · Cited by 152
Senga, S., Kobayashi, N., Kawaguchi, K., Ando, A., & Fujii, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.010 · Cited by 142
Li, Q., Wang, Z., Xie, Y., & Hu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109955 · Cited by 142
Pacifico, F., & Leonardi, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.032 · Cited by 145
Chua, A. W. L., Hay, H. S., Rajendran, P., Shanmugam, M. K., Li, F., Bist, P., Koay, E. S.-C., Lim, L. H. K., Kumar, A. P., & Sethi, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.045 · Cited by 140
Kim, J. H., Gupta, S. C., Park, B., Yadav, V. R., & Aggarwal, B. B. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100270 · Cited by 145
Yuan, Z., Guan, Y. A., Wang, L., Wei, W., Kane, A. B., & Chin, Y. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9390-9400.2004 · Cited by 137
Metadata
- Authors
- Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H.
- Affiliations
- Indiana University Indianapolis (US)
- Walther Cancer Foundation (US)
- Corresponding author
- Nakshatri, Harikrishna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21631-21638
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980790180
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 12 · 2022: 19 · 2021: 14 · 2020: 23 · 2019: 18 · 2018: 33 · 2017: 28 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 42 · 2012: 18
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health (5r21ca082208-02)
- National Heart, Lung, and Blood Institute (HL67384, R01HL067384)
- National Cancer Institute (CA82208)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053674, DK53674, T32DK007519)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- NF-κB, breast cancer, metastasis, cell migration, CXCR4, chemokine receptors, SDF-1α, chemokine signaling, IκB, transcriptional regulation, lung metastasis
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Chemotaxis, Flow Cytometry, Genetic Vectors, Humans, Neoplasm Metastasis, Neoplasm Transplantation, Plasmids, Promoter Regions, Genetic, Ribonucleases, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Up-Regulation, Gene Expression Regulation, Neoplastic, NF-kappa B, DNA, Complementary, COS Cells, Receptors, CXCR4, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, Transcription Factor RelA, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review